Diabetes and the Cardiometabolic Continuum

(P100) CDCES Providers: Knowledge, Attitudes and Practices of Hearing Impairment with Diabetes

(P102) Create a Glycemic Management Platform in Your Hospital Using Your Diabetes Expertise

(P103) Efficacy and Safety of Sotagliflozin, a Dual Sodium-Glucose Cotransporter 1-2 Inhibitor, in Patients with Type 1Diabetes and Chronic Kidney Disease: A Post-Hoc Analysis of the inTandem Studies

(P104) Impact of Sotagliflozin, a Dual Sodium-Glucose Cotransporter 1-2 Inhibitor, as Add-on to Inadequately Controlled Basal Insulin-Treated Type 2 Diabetes

(P105) Patient Reported Burden of Disease in Diabetic Peripheral Neuropathic Pain: Learnings from In-depth Patient Interviews, Sub-Study of RELIEF-DPN 1

(P107) Support Preferences of Low-Income Postpartum Women Following a Diabetes-Complicated Pregnancy

(P108) Ongoing Treatments with High Concentration Capsaicin Topical System Results in Progressive Pain Reduction for Painful Diabetic Neuropathy: A Retrospective Real-World Analysis

(P109) Comparing Characteristics and Prescribing Patterns Among Patients with T2D and Established ASCVD with and without Cardioprotective Medications

(P114) Increase Your Comfort in Addressing Erectile Dysfunction - A Major Concern for Men Living with Diabetes

(P115) Results from the CATALYST Trial Part 1

(P119) Lowering Blood Glucose with Tetrahydrocannabivarin (THCV): What Does the Literature Say?